Virios Said In Shareholder Letter, We Are Exploring Options To Advance The IMC-2 LC Investigational New Drug Application And Its Proposed Phase 2 Research Program
维里奥斯在股东信中表示,我们正在探索推进 IMC-2 LC 研究性新药申请及其拟议的第二阶段研究计划的备选方案
Virios Said In Shareholder Letter, We Are Exploring Options To Advance The IMC-2 LC Investigational New Drug Application And Its Proposed Phase 2 Research Program
维里奥斯在股东信中表示,我们正在探索推进 IMC-2 LC 研究性新药申请及其拟议的第二阶段研究计划的备选方案
使用浏览器的分享功能,分享给你的好友吧